Apolipoprotein E genotyping as a diagnostic adjunct for Alzheimer's disease

Area of Science:

• Neuroscience
• Genetics
• Medical Diagnostics

Background:

• Alzheimer's disease (AD) diagnosis relies on accurate predictive tests.
• The Apolipoprotein E (Apo E) gene, specifically the epsilon 4 allele, is a known susceptibility factor for AD.
• Early diagnostic utility is crucial for effective disease management.

Purpose of the Study:

• To evaluate the positive predictive value (PPV) of Apolipoprotein E (Apo E) genotyping for Alzheimer's disease (AD) diagnosis.
• To assess the practical utility of Apo E genotyping in early AD detection.

Main Methods:

• Analysis of Apo E allele frequencies in patients diagnosed with possible or probable AD.
• Review of existing studies measuring specificity, sensitivity, PPV, and negative predictive value (NPV) of Apo E genotyping.

Main Results:

• Apolipoprotein E (Apo E) epsilon 4 allele is present in over 50% of patients with cognitive impairment of the Alzheimer type.
• The positive predictive value (PPV) of Apo E genotyping for AD exceeds 97% in specific patient cohorts.
• Apo E genotyping is the only diagnostic adjunct rigorously measured for PPV and NPV.

Conclusions:

• Apo E genotyping provides significant diagnostic information for Alzheimer's disease (AD).
• The diagnostic accuracy of Apo E genotyping is expected to improve with the identification of additional genetic risk factors.
• The paradigm for AD diagnosis is shifting towards incorporating genetic markers.